More recently, it was reported that loss of POB1 expression during human prostate cancer progression, from androgen-dependent to growth factors dependent, results in loss of control of cell growth signaling while induced expression of POB1 causes a reduction of several EGF-responsive genes (e.g., Fos and Jun). The gene discussed is REPS2; the disease is prostate carcinoma.